The drug significantly reduced growth of MDA-MB-453 MIND xenograft tumours, as determined using bioluminescent imaging (Fig. 4b) and reduced protein expression of MCL-1 in tumours (Fig. 4c; Supplementary Fig. 3a). The gene discussed is MCL1; the disease is neoplasm.